FLT3突变的AML:通过外体介导机制的免疫逃避和针对免疫逃脱的创新组合疗法

Mohamed J Saadh1, Waleed K Abdulsahib2, Dilfuza Ashurova3

  • 1Faculty of Pharmacy, Middle East University, Amman, Jordan.

概括

在急性髓性白血病 (AML) 中FLT3突变促进免疫逃避. 向外体路径提供了一个有希望的策略,以增强免疫识别和改善FLT3突变AML患者的患者结果.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K